Next Issue
Volume 101, ISCDISD 2023
Previous Issue
Volume 99, ESSUAlg 2024
 
 
proceedings-logo

Journal Browser

Journal Browser

Proceedings, 2024, IECC 2024

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Number of Papers: 20
Order results
Result details
Select all
Export citation of selected articles as:

Research

125 KiB  
Abstract
Hidden Gems in the Genome: Pseudogenes Unleashing Revolution in Hepatocellular Carcinoma Detection and Therapy
by Kritika Chugh
Proceedings 2024, 100(1), 1; https://doi.org/10.3390/proceedings2024100001 - 27 Mar 2024
Viewed by 190
Abstract
Hepatocellular Carcinoma (HCC), a formidable global health challenge, continues to claim numerous lives due to its asymptomatic nature in the early stages and limited treatment options. In this ever-evolving landscape of cancer research, pseudogenes, once relegated to the genetic sidelines as ‘non-functional’, have [...] Read more.
Hepatocellular Carcinoma (HCC), a formidable global health challenge, continues to claim numerous lives due to its asymptomatic nature in the early stages and limited treatment options. In this ever-evolving landscape of cancer research, pseudogenes, once relegated to the genetic sidelines as ‘non-functional’, have emerged as intriguing players. Contrary to their historical dismissal, pseudogenes are now recognized for their intricate roles in modulating gene expression and contributing to the complex molecular milieu of cancer. This comprehensive review delves into the uncharted territory of pseudogenes and their potential to revolutionize HCC detection and treatment. From deciphering the molecular connections between pseudogenes and HCC to exploring their utility as diagnostic biomarkers, prognostic indicators, and therapeutic targets, this article aims to solve the enigma of pseudogenes in hepatocellular carcinoma. Full article
2 pages, 129 KiB  
Abstract
Pulmonary Tuberculosis: A Comorbidity or Misdiagnosis of Primary Lung Cancer in Africa?
by Tinashe Adrian Mazhindu, Ntokozo Ndlovu, Edith Matsikidze, Shirley Chibonda and Webster Kadzatsa
Proceedings 2024, 100(1), 2; https://doi.org/10.3390/proceedings2024100002 - 12 Apr 2024
Viewed by 378
Abstract
Background: Globally, over 2 million new cases of lung cancer are diagnosed annually, representing about 11% of all cancers [...] Full article
134 KiB  
Abstract
Exploring BNCT as a Novel Approach for Metastatic Spinal Tumor Management
by Yoshiki Fujikawa, Shinji Kawabata, Kohei Tsujino, Ryo Kayama, Hideki Kashiwagi, Yusuke Fukuo, Ryo Hiramatsu, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Naonori Hu, Shin-Ichi Miyatake, Toshihiro Takami and Masahiko Wanibuchi
Proceedings 2024, 100(1), 3; https://doi.org/10.3390/proceedings2024100003 - 27 Mar 2024
Viewed by 128
Abstract
[Background] Boron neutron capture therapy (BNCT) is a particle beam therapy that enables the precise targeting of tumors at the cellular level [...] Full article
147 KiB  
Abstract
Development of Synergetic Combinations of a Novel Apoptosis Inducer with AKT and Hsp90 Selective Inhibitors Targeting Hormone-Sensitive and Hormone-Resistant Breast Cancer Cells
by Diana I. Salnikova, Stepan K. Krymov, Danila V. Sorokin, Fedor B. Bogdanov, Olga E. Andreeva, Alvina I. Khamidullina, Andrey E. Shchekotikhin and Alexander M. Scherbakov
Proceedings 2024, 100(1), 4; https://doi.org/10.3390/proceedings2024100004 - 27 Mar 2024
Viewed by 158
Abstract
Introduction: The design and development of antitumor compounds based on an isatin core led to the synthesis of 1-substituted isatin-5-sulfonamides with potent antiproliferative activity [...] Full article
149 KiB  
Abstract
Aberrantly Expressed Long Non-Coding RNAS and mRNAS in Breast Cancer and Their Interaction
by Elena Filippova, Svetlana Lukina, Irina Pronina, Alexey Burdenny, Tatiana Kazubskaya, Vitaly Loginov and Eleonora Braga
Proceedings 2024, 100(1), 5; https://doi.org/10.3390/proceedings2024100005 - 27 Mar 2024
Viewed by 148
Abstract
According to the latest global statistics for 2020, breast cancer (BC) has taken first place in the incidence of epithelial tumors, ahead of lung cancer, and is the main cause of mortality from cancer pathology among women around the world [...] Full article
124 KiB  
Abstract
The Suppression of Medulloblastoma Cell Migration Using Clinically Significant Doses of Simvastatin through Mevalonate Pathway Targeting
by Charley Comer and Maria Victoria Niklison-Chirou
Proceedings 2024, 100(1), 6; https://doi.org/10.3390/proceedings2024100006 - 27 Mar 2024
Viewed by 111
Abstract
Aims: Medulloblastoma (MBs), the most prevalent malignant paediatric brain tumour, exhibits distinct subgroups—Wingless (WNT), Sonic Hedgehog (SHH), Group 3 (G3), and Group 4 (G4)—and each is characterized by unique molecular signatures and clinical outcomes [...] Full article
126 KiB  
Abstract
Development of Letrozole-Loaded Magnetic Nanoemulsion Used for Breast Cancer Treatment
by Dharshana Karthikeyan, Latha Subbiah and Selvamani Palanisamy
Proceedings 2024, 100(1), 7; https://doi.org/10.3390/proceedings2024100007 - 27 Mar 2024
Viewed by 132
Abstract
Introduction: Emulsions are attractive delivery systems for hydrophobic drug molecules compared to hydrophilic drug molecules [...] Full article
157 KiB  
Abstract
Synthesis and Preliminary Investigation of Metal Nanoparticles from the Stem Extract of Bacopa sp. for the Treatment of Lung Cancer
by Yogeshwaran Murugan, Selvamani Palanisamy and Latha Subbiah
Proceedings 2024, 100(1), 8; https://doi.org/10.3390/proceedings2024100008 - 27 Mar 2024
Viewed by 179
Abstract
Lung cancer is the third most common cancer in women and the most common cancer in males. Chemotherapy, allopathy, hormone therapy, radiation therapy, surgery, immune system, and targeted therapies are frequently used to treat lung cancer. These medications induce other diseases and have [...] Read more.
Lung cancer is the third most common cancer in women and the most common cancer in males. Chemotherapy, allopathy, hormone therapy, radiation therapy, surgery, immune system, and targeted therapies are frequently used to treat lung cancer. These medications induce other diseases and have a variety of negative effects. Thus, we used a different strategy and sought to treat lung cancer with medicinal herbs. We selected the perennial creeping herb Bacopa monnieri, which belongs to the Scrophulariaceae family, among other medicinal herbs. It contains several active phytoconstituents, including sterols, alkaloids, flavanoids, terpenoids, and saponins. The primary component with anti-lung cancer efficacy is phytosterol, according to the components. According to the phytochemical investigation, this plant contained it. The literature review indicates that the problem is lessened by nanoparticle production. Thus, the novelty of our work is the manufacture of zinc oxide nanoparticles for the treatment of lung cancer using BM stem extracts. Researchers have been interested in ZnO material because of its huge band gap (3.37 eV) with n-type semi-conductivity and high excitonic binding energy (60 meV) with regards to the different semiconductor nanomaterials, such as TiO2, SnO2, GaN, CuO, GaAs, Si, and ZnO. Zinc oxide in bulk is economical and can be used for many different industrial processes, such as the creation of nanoparticles. Zinc acetate serves as the precursor and stem extract serves as the reducing agent in the synthesis. The absorbance peak between 300 and 400 nm in UV spectroscopy was used to characterize the ZnO nanoparticles that were produced from hydromethanolic BM stem extract. In later research, lung cancer treatment might be considered. Given that lung (A549) cell lines will be treated with phytosterol-containing hydromethanolic BM stem extract in the form of ZnO nanoparticles, which will cause cell death by reducing cell proliferation, DNA damage and apoptosis may occur. Full article
134 KiB  
Abstract
Optimization and Development of Magnetically Triggered Letrozole Nanoliposomes for Breast Cancer Targeting
by Madhumethra Ramasamy Govindaraj, Latha Subbiah and Selvamani Palanisamy
Proceedings 2024, 100(1), 9; https://doi.org/10.3390/proceedings2024100009 - 27 Mar 2024
Viewed by 151
Abstract
Background: Breast cancer is one of the most frequently diagnosed cancers and is the leading cause of death among women worldwide [...] Full article
172 KiB  
Abstract
Pharmacological Network Study on the Effect of Quercetin on Gastric Cancer Using Computerized Databases
by Sergio Raúl Zúñiga-Hernández, Trinidad García-Iglesias, Monserrat Macías-Carballo, Juan Manuel Guzmán-Flores and Christian Martin Rodríguez-Razón
Proceedings 2024, 100(1), 10; https://doi.org/10.3390/proceedings2024100010 - 27 Mar 2024
Viewed by 155
Abstract
Gastric cancer (GC) is the second most common cause of death of any cancer-related cases in the world, and is also in the top 5 most common malignancy cancers in general. There are plenty of well-distributed treatments, offering better hygiene, more robust and [...] Read more.
Gastric cancer (GC) is the second most common cause of death of any cancer-related cases in the world, and is also in the top 5 most common malignancy cancers in general. There are plenty of well-distributed treatments, offering better hygiene, more robust and complete nutrition, and the eradication of pathogens such as Helicobacter pylori. Currently, there is still the need for more treatments, especially those of lower cost, like those coming from already easily available products. Quercetin (QRC) is a natural phenolic compound present in a wide variety of products, e.g., in plants like Hibiscus sabdariffa, onions, grapes, broccoli, and citrus fruits. This product has been shown to have great potential therapeutic effects, and it has also been suggested that it could be useful in combating different types of cancer; however, information regarding the targets or mechanisms that QRC has on cancer cells is still unclear. Therefore, this study aims to identify the targets that QRC has, like anti-cancer treatment for GC using different bio-informatic tools and databases. From MalaCards and SwissTargetPrediction, both QRC and GC molecular targets were defined, and then they were matched with the Venny 2.1.0 platform. From this, 31 genes were gathered, and then they were analyzed using the ShinnyGo0.77 and DAVID-Bioinformatic Resources. Furthermore, StringDB was used to identify the protein—protein interactions, and Citoscape 3.6.0 12 hub genes were obtained. Those hub genes were then subject to Gene Expression Profiling Interactive Analysis and TISIDB. Finally, molecular docking studies were performed using the SwissDock database. The results suggest that, according to the gene ontology data, QRC has a relationship with the regulation of cell death, response to stress, cell motility, response to amyloid-beta, cellular response to reactive oxygen species, and apoptotic processes. Some genes like EGFR were correlated with an abundance of CD8 and Neutrophil infiltration but didn’t show to improve the survival rate. Furthermore, molecular docking results show that QRC can bind to multiple molecules of interest. These results complement some of the currently available information alluding to the effectiveness of plants rich with QRC as part of the treatment used for different kinds of cancer, but it also suggests a plethora of new targets that this molecule has in GC, while at the same time giving a clearer idea of the mechanisms that are affected in GC by QRC. However, as with any other study that primarily uses bioinformatic tools, these final results are to be used for more direct and precise research, especially if experimental protocols are used. Full article
145 KiB  
Abstract
Differential Expression Analysis in Genes Associated with the Mitochondrial Metabolism Reveals a Potential Influence on the Progression of Glioblastoma from Astrocytoma
by Ricardo Cunha de Oliveira and Giovanna Chaves Cavalcante
Proceedings 2024, 100(1), 11; https://doi.org/10.3390/proceedings2024100011 - 27 Mar 2024
Viewed by 144
Abstract
The most common forms of primary brain tumors are low-grade astrocytoma (ACT) tumors and their progression to the glioblastoma multiforme (GBM), in a high-aggressiveness form. Understanding mechanisms of progression is necessary, and mitochondrial mechanisms are not yet as well elucidated and may be [...] Read more.
The most common forms of primary brain tumors are low-grade astrocytoma (ACT) tumors and their progression to the glioblastoma multiforme (GBM), in a high-aggressiveness form. Understanding mechanisms of progression is necessary, and mitochondrial mechanisms are not yet as well elucidated and may be a factor in this disease. Therefore, in this study, we analyzed differential gene expression (DGE) between GBM and ACT, using the MitoXplorer 2.0 to screen nuclear genes involved in mitochondrial metabolism, totaling 1193 genes. The analysis used ACT (n = 195) and GBM (n = 157) samples made available by The Cancer Genome Atlas (TCGA) database. As a complement, we checked the expression of differentially expressed genes (DEGs) in normal tissues using the GTEx Portal, as well as checking disease-free survival (DFS) using GEPIA2. DGE showed five potential DEGs, three of which were downregulated (ACSM2A, ACSM2B, and PRODH2) and two were upregulated (TERT and FBP2). In non-cancerous tissues, upregulated DEGs are normally expressed basally in brain tissue and TERT is normally expressed in tissues such as testis and small intestine, while FBP2 is expressed in the stomach, skeletal muscle, testis, pancreas, and adrenal glands. Alternatively, downregulated DEGs normally show basal or zero expression in brain tissues and are normally expressed in the liver and kidneys. DFS analysis showed that the high expression of the TERT is associated with poor survival, and is the only gene found to be significant among the five DEGs (p-value 0.05). Briefly, our analyses showed five mitochondrial DEGs as potential markers of GBM progression in relation to ACT. Four of the five DEGs have not been reported as factors that can influence the GBM cascade until this work, while the TERT gene has already been indicated as a potential biomarker of brain cancer, having an essential function in the protection of the mitochondrial genome. Full article
115 KiB  
Abstract
Machine Learning Strategies for Drug Discovery in AML: Focus on RUNX1 Bioactivity
by Deepesh Kumar Verma
Proceedings 2024, 100(1), 12; https://doi.org/10.3390/proceedings2024100012 - 27 Mar 2024
Viewed by 125
Abstract
Acute myeloid leukemia (AML) is an aggressive blood cancer where immature stem cells in the bone marrow multiply rapidly, disrupting blood cell production and leading to infections, anemia, and bleeding [...] Full article
135 KiB  
Abstract
Chordoma Treatment with Boron Neutron Capture Therapy (BNCT): Experimental Insights
by Yoshiki Fujikawa, Shinji Kawabata, Kohei Tsujino, Hideki Kashiwagi, Yusuke Fukuo, Ryo Hiramatsu, Hiroki Tanaka, Naonori Hu, Toshihiro Takami and Masahiko Wanibuchi
Proceedings 2024, 100(1), 13; https://doi.org/10.3390/proceedings2024100013 - 27 Mar 2024
Viewed by 122
Abstract
Boron Neutron Capture Therapy (BNCT) is a particle beam therapy that enables the precise targeting of tumors at the cellular level [...] Full article
161 KiB  
Abstract
Polycyclic Aromatic Hydrocarbons (PAHs) in Grilled Marshmallows
by Maciej Maciejczyk, Beata Janoszka, Magdalena Szumska, Beata Pastuszka, Sławomir Waligóra, Aleksandra Damasiewicz-Bodzek, Agnieszka Nowak and Krystyna Tyrpień-Golder
Proceedings 2024, 100(1), 14; https://doi.org/10.3390/2024100014 - 27 Mar 2024
Viewed by 160
Abstract
Introduction [...] Full article
146 KiB  
Abstract
Evaluation of the Safety of Folate Receptor-Targeted Boron Carrier in Boron Neutron Capture Therapy (BNCT) for Malignant Gliomas Using CED Administration
by Kohei Tsujino, Hideki Kashiwagi, Ryo Kayama, Yoshiki Fujikawa, Yusuke Fukuo, Ryo Hiramatsu, Naosuke Nonoguchi, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Naonori Hu, Masahiko Wanibuchi, Kei Nakai, Kai Nishimura, Hiroyuki Nakamura and Shinji Kawabata
Proceedings 2024, 100(1), 15; https://doi.org/10.3390/proceedings2024100015 - 27 Mar 2024
Viewed by 82
Abstract
Knowing how to accumulate boron into the tumor cells is a crucial aspect of boron neutron capture therapy (BNCT), which can be targeted at the cellular level, and the development of novel boron agents other than BPA, which is used in clinical practice, [...] Read more.
Knowing how to accumulate boron into the tumor cells is a crucial aspect of boron neutron capture therapy (BNCT), which can be targeted at the cellular level, and the development of novel boron agents other than BPA, which is used in clinical practice, is urgently needed [...] Full article
160 KiB  
Abstract
Post-GWAS Functional Analysis of the 11p11.2 Risk Locus Identifies HSD17B12 as a Neuroblastoma Susceptibility Gene Involved in Lipid Metabolism
by Teresa Maiorino, Marianna Avitabile, Vito Alessandro Lasorsa, Annalaura Montella, Sueva Cantalupo, Matilde Tirelli, Martina Morini, Alessandra Eva, Marianna Caterino, Margherita Ruoppolo, John M. Maris, Sharon J. Diskin, Achille Iolascon and Mario Capasso
Proceedings 2024, 100(1), 16; https://doi.org/10.3390/proceedings2024100016 - 27 Mar 2024
Viewed by 93
Abstract
Genome-wide association studies (GWASs) have contributed to the study of neuroblastoma (NB) genetics by identifying common risk variants that activate cancer-related processes associated with NB susceptibility [...] Full article
150 KiB  
Abstract
Deciphering the Role of USP16 in Lung Cancer
by Valentina Serratore, Carmen Di Ruocco, Annamaria Cerantonio, Carmela De Marco and Giuseppe Viglietto
Proceedings 2024, 100(1), 17; https://doi.org/10.3390/proceedings2024100017 - 27 Mar 2024
Viewed by 100
Abstract
Deubiquitylating enzymes are proteases that reverse the ubiquitination of proteins, an important process for maintaining normal homeostasis [...] Full article
170 KiB  
Abstract
Noncoding Regulatory Mutations as a Driving Event for the Oncogenic Core Regulatory Circuitries of Neuroblastoma
by Vincenzo Aievola, Vito Alessandro Lasorsa, Annalaura Montella, Ferdinando Bonfiglio, Marianna Avitabile, Teresa Maiorino, Matilde Tirelli, Giuseppe D’Alterio, Matthias Fischer, Frank Westermann, Achille Iolascon and Mario Capasso
Proceedings 2024, 100(1), 18; https://doi.org/10.3390/proceedings2024100018 - 27 Mar 2024
Viewed by 40
Abstract
Neuroblastoma (NB) is a pediatric tumor composed of adrenergic (ADRN) and mesenchymal-like (MES) cells which derive from the dysregulation of normal cell differentiation imposed by NB Core Regulatory Circuitries (CRCs) [...] Full article
144 KiB  
Abstract
Exposure to Mycovirus-Containing Aspergillus flavus Alters Transcription Factors in Normal and Leukemia Cell Lines
by Cameron K. Tebbi, Eva Sahakian, Jiyu Yan, Saumil Patel and Melanie Mediavilla-Varela
Proceedings 2024, 100(1), 19; https://doi.org/10.3390/proceedings2024100019 - 27 Mar 2024
Viewed by 39
Abstract
Transcription factors bind specific DNA motifs to regulate the expression of target genes in order to maintain normal hematopoiesis [...] Full article
139 KiB  
Abstract
Exploring the Antimicrobial and Anticancer Potential of a Bioactive Peptide from T. radiatus: A Comprehensive Study
by Krishnanand Nagarajan, Latha Subbaiah and Selvamani Palanisamy
Proceedings 2024, 100(1), 20; https://doi.org/10.3390/proceedings2024100020 - 27 Mar 2024
Viewed by 24
Abstract
Therapeutic peptides have emerged as a promising frontier in the development of anti-cancer agents, classified into three main groups: antimicrobial/pore-forming peptides, cell-permeable peptides, and tumor-targeting peptides [...] Full article
Back to TopTop